Citigroup Upgrades agilon health (NYSE:AGL) to “Neutral”

agilon health (NYSE:AGL) was upgraded by stock analysts at Citigroup from a “sell” rating to a “neutral” rating in a research note issued on Friday, MarketBeat.com reports. The firm currently has a $2.25 price target on the stock, up from their prior price target of $1.75. Citigroup’s target price indicates a potential downside of 7.02% from the stock’s previous close.

Other equities analysts have also issued reports about the company. Sanford C. Bernstein began coverage on agilon health in a research note on Wednesday, December 11th. They set a “market perform” rating and a $2.50 price target on the stock. Barclays decreased their price objective on agilon health from $5.00 to $2.00 and set an “underweight” rating on the stock in a report on Monday, November 11th. TD Cowen cut their target price on agilon health from $6.00 to $2.00 and set a “hold” rating for the company in a research note on Monday, November 11th. Stifel Nicolaus decreased their price target on shares of agilon health from $7.00 to $2.00 and set a “hold” rating on the stock in a research note on Tuesday, November 12th. Finally, Bank of America lowered shares of agilon health from a “buy” rating to an “underperform” rating and set a $3.00 price target on the stock. in a report on Wednesday, October 2nd. Two research analysts have rated the stock with a sell rating, fourteen have given a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $3.98.

agilon health Stock Up 10.5 %

Shares of AGL stock opened at $2.42 on Friday. agilon health has a 12 month low of $1.50 and a 12 month high of $8.20. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 0.06. The firm has a market cap of $997.08 million, a PE ratio of -2.57 and a beta of 0.53. The stock has a 50 day moving average of $2.07 and a 200-day moving average of $3.75.

agilon health (NYSE:AGL) last released its earnings results on Thursday, November 7th. The company reported ($0.29) EPS for the quarter, missing the consensus estimate of ($0.10) by ($0.19). agilon health had a negative net margin of 6.88% and a negative return on equity of 47.84%. The company had revenue of $1.45 billion for the quarter, compared to analyst estimates of $1.47 billion. During the same quarter in the previous year, the company earned ($0.06) earnings per share. On average, equities analysts predict that agilon health will post -0.52 EPS for the current year.

Insider Buying and Selling

In related news, Director Diana Mckenzie bought 12,500 shares of the company’s stock in a transaction on Monday, November 25th. The stock was bought at an average cost of $2.28 per share, with a total value of $28,500.00. Following the completion of the purchase, the director now owns 51,319 shares in the company, valued at approximately $117,007.32. The trade was a 32.20 % increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Director John William Wulf purchased 45,000 shares of the firm’s stock in a transaction dated Thursday, December 5th. The shares were bought at an average cost of $2.18 per share, for a total transaction of $98,100.00. Following the completion of the purchase, the director now directly owns 206,133 shares of the company’s stock, valued at $449,369.94. The trade was a 27.93 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have purchased a total of 90,000 shares of company stock worth $198,100 in the last 90 days. Corporate insiders own 3.20% of the company’s stock.

Institutional Investors Weigh In On agilon health

Hedge funds and other institutional investors have recently made changes to their positions in the company. AQR Capital Management LLC increased its position in agilon health by 3,338.5% in the second quarter. AQR Capital Management LLC now owns 1,356,438 shares of the company’s stock worth $8,871,000 after purchasing an additional 1,316,990 shares during the period. Susquehanna Fundamental Investments LLC boosted its stake in shares of agilon health by 65.0% in the 2nd quarter. Susquehanna Fundamental Investments LLC now owns 804,594 shares of the company’s stock valued at $5,262,000 after purchasing an additional 316,856 shares during the last quarter. Citigroup Inc. grew its position in shares of agilon health by 2,251.5% during the 3rd quarter. Citigroup Inc. now owns 2,028,246 shares of the company’s stock worth $7,971,000 after buying an additional 1,941,993 shares during the period. Healthcare of Ontario Pension Plan Trust Fund bought a new stake in shares of agilon health during the second quarter worth approximately $1,849,000. Finally, Geode Capital Management LLC lifted its holdings in agilon health by 1.2% in the third quarter. Geode Capital Management LLC now owns 6,893,517 shares of the company’s stock valued at $27,097,000 after buying an additional 84,889 shares during the period.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.